rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Christian Angermayer

Director and 10% owner

Company insider

Files Form 4 as: Director and 10% owner, Enhanced Group; Director and 10% owner, AtaiBeckley; Director and 10% owner, ATAI Life Sciences; 10% owner, Faeth Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
63
Buys
16
Sells
1
Bought
$23.8M
Sold
$5.4M
Companies
4
Companies where not an officer
4
First trade
22 Jun 2021
Last trade
17 Sep 2026
Last filed
21 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ENHA Enhanced GroupDirector, 10% owner · Entertainment, Gaming & Leisure Services · last 17 Sep 20267 buys · 0 sells
AtaiBeckleyDirector, 10% owner · Biotechnology · last 11 Sep 20260 buys · 0 sells
ATAI Life SciencesDirector, 10% owner · last 26 Jun 20259 buys · 0 sells
FTH Faeth Therapeutics10% owner · Biotechnology · last 1 Jun 20230 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
04Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Sep 2026filed 21 Sep 2026ENHA Enhanced GroupEntertainment, Gaming & Leisure ServicesSEC FORM 4 Bought$7.0M6,080,047 at $1.15filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyBiotechnologySEC FORM 4 Code D—559,232filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—121,968filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyBiotechnologySEC FORM 4 Code D—53,398,214filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyBiotechnologySEC FORM 4 Code D—1,799,302filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—624,000filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—64,000filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—17,930filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—1,247,932filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—131,698filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—103,000filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—121,968filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—624,000filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—64,000filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—17,930filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—1,247,932filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—131,698filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyoption or derivative · BiotechnologySEC FORM 4 Code D—103,000filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyBiotechnologySEC FORM 4 Code D—559,232filing
11 Sep 2026filed 11 Sep 2026AtaiBeckleyBiotechnologySEC FORM 4 Code D—53,398,214filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Consumer Discretionary7
Health Care1
Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Michael SepsoDirector · Director at Enhanced Group, filing Form 4 there in the last year
Juliette HanDirector · Director at Enhanced Group, filing Form 4 there in the last year
Anthony D. EisenbergDirector · Director at Enhanced Group, filing Form 4 there in the last year
James Gaskill SimpsonDirector · Director at Enhanced Group, filing Form 4 there in the last year
Apeiron Investment Group Ltd.Director and 10% owner · Director and 10% owner at Enhanced Group, filing Form 4 there in the last year